clozapine N-oxide

临床试验

计划入组 112 人 · 首次发布于 2018 年 2 月 1 日

已完成

NCT02558673

Trimethylamine-N-oxide Production and Metabolism

计划入组 40 人 · 首次发布于 2015 年 9 月 24 日

已完成

NCT06580431

Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease

计划入组 100 人 · 首次发布于 2024 年 8 月 30 日

药物

查看全部 2294 →

Small Molecule

Experimental

Dodecyldimethylamine N-oxide

C₁₄H₃₁NO

Small Molecule

Approved

Clozapine(Clozaril, Fazaclo, Versacloz)

生产企业：Azur pharma international iii ltd, Caraco pharmaceutical laboratories ltd，另有 5 家

相关疾病：Suicidal Behaviour, Treatment Resistant Schizophrenia，另有 1 项

C₁₈H₁₉ClN₄ · Rx

Small Molecule

Experimental

Capric dimethyl amine oxide

C₁₂H₂₇NO

机构

查看全部 94 →

NITROUS OXIDE

United States

Nitrous Oxide Corp.

United States

Nitrous Oxide Corp

United States

资讯

查看全部 1987 →

去年

Ultrasound-Activated Nanoparticles Enable Precise Drug Delivery to Deep Brain Regions in Primates

去年

FDA Advisory Committees Vote to Dismiss Clozapine REMS, Citing Barriers to Access

去年

临床试验

Trimethylamine N-oxide in Myocardial Infarction

Trimethylamine-N-oxide Production and Metabolism

Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease

药物

Dodecyldimethylamine N-oxide

Clozapine(Clozaril, Fazaclo, Versacloz)

Capric dimethyl amine oxide

机构

NITROUS OXIDE

Nitrous Oxide Corp.

Nitrous Oxide Corp

资讯

Ultrasound-Activated Nanoparticles Enable Precise Drug Delivery to Deep Brain Regions in Primates

FDA Advisory Committees Vote to Dismiss Clozapine REMS, Citing Barriers to Access

FDA Advisory Committee Recommends Dismantling Clozapine REMS Program